|
Diabetes Care, Vol 14, Issue 11 958-962, Copyright © 1991 by American Diabetes Association
Skin reactive hyperemia in diabetic patients. A study by laser Doppler flowmetry
E Tur, G Yosipovitch and Y Bar-On
Department of Dermatology, Ichilov Medical Center, Tel Aviv, Israel.
OBJECTIVE: To assess whether laser Doppler flowmetry could detect
differences in the cutaneous response to postischemic reactive hyperemia
between patients with non-insulin-dependent diabetes mellitus (NIDDM) and
nondiabetic controls and among subgroups of NIDDM patients. RESEARCH DESIGN
AND METHODS: We measured the cutaneous blood flow on the forearms during
the postischemic reactive hyperemia test in diabetic patients and
nondiabetic controls. Subjects were 25 patients with NIDDM from the
outpatient clinics of dermatology, ophthalmology, and endocrinology and 25
nondiabetic volunteers matched for sex and age. Of the patients with NIDDM,
14 had proliferative retinopathy, and 13 were obese. Cutaneous postischemic
reactive hyperemia test monitored by measuring the cutaneous blood flow
with laser Doppler flowmetry was used. Peak blood flow (P) after arterial
occlusion, the time required to reach this peak (Tp) and the ratio (K)
between these two quantities (K = P/Tp) were measured. RESULTS: In diabetic
patients, P was significantly lower (P less than 0.02) than in nondiabetic
control subjects. In diabetic patients with proliferative retinopathy, K
was lower (P less than 0.05) than in diabetic patients without retinopathy.
Diabetic patients with a body mass index (BMI; wt/ht2) less than 25 kg/m2
had a longer Tp (P less than 0.002), whereas the control group BMI did not
affect this parameter. The combination of retinopathy and BMI less than 25
gave the longest Tp values (P less than 0.0001). CONCLUSIONS: Postischemic
hyperemia tests in diabetic patients reveal cutaneous microcirculatory
changes in the forearm (lower P). Advanced retinopathy is associated with
functional disturbances (lower K), especially when combined with a low BMI
(less than 25; longer Tp).

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. S. Medow, I. Taneja, and J. M. Stewart
Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H425 - H432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Stewart, A. Kohen, D. Brouder, F. Rahim, S. Adler, R. Garrick, and M. S. Goligorsky
Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2687 - H2696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Binggeli and G. Noll
Reply
J. Am. Coll. Cardiol.,
June 2, 2004;
43(11):
2147 - 2148.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Wong, B. W. Wilkins, L. A. Holowatz, and C. T. Minson
Nitric oxide synthase inhibition does not alter the reactive hyperemic response in the cutaneous circulation
J Appl Physiol,
August 1, 2003;
95(2):
504 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Binggeli, L. E. Spieker, R. Corti, I. Sudano, V. Stojanovic, D. Hayoz, T. F. Luscher, and G. Noll
Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: A monitoring test of endothelial dysfunction for clinical practice?
J. Am. Coll. Cardiol.,
July 2, 2003;
42(1):
71 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fromy, P. Abraham, C. Bouvet, B. Bouhanick, P. Fressinaud, and J. L. Saumet
Early Decrease of Skin Blood Flow in Response to Locally Applied Pressure in Diabetic Subjects
Diabetes,
April 1, 2002;
51(4):
1214 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yosipovitch, J. Schneiderman, D. J. van Dyk, A. Chetrit, G. Milo, and G. Boner
Impairment of the Postural Venoarteriolar Response in Young Type 1 Diabetic Patients: A Study by Laser Doppler Flowmetry
Angiology,
July 1, 1996;
47(7):
687 - 691.
[Abstract]
[PDF]
|
 |
|
Copyright © 1991 by the American Diabetes Association.
|
|
| |
|